Clinical Trial Update: Low or High Botox Dilution for the Hemiplegic Gait? [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating low versus high dilution of Botox (onabotulinumtoxinA) for improving gait in individuals with post-stroke spasticity-related h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-stroke Spasticity

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: University of Ioannina | Conditions: Post Stroke Spastic Hemiplegia | Phase 1 | Status: RECRUITING